Harry L Keyserling - JoVE Visualize

Showing results (1-10 of 18) with videos related to

Pageof 2

Sort By:

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2005

Invasive infections with Haemophilus influenzae serotype a containing an IS1016-bexA partial deletion: possible association with virulenceBill G Kapogiannis, Sarah Satola, Harry L Keyserling, et al.

Expert Review of Vaccines|September 23, 2006

Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135Harry L Keyserling, Andrew J Pollard, Lisa M DeTora, et al.

Tropical Medicine & Surgery|September 16, 2014

Enrollment in YFV Vaccine Trial: An Evaluation of Recruitment Outcomes Associated with a Randomized Controlled Double-Blind Trial of a Live Attenuated Yellow Fever VaccinePaula M Frew, Eve T Shapiro, Lu Lu, et al.

BMC Infectious Diseases|March 19, 2010

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasonsLisa A Jackson, Manjusha J Gaglani, Harry L Keyserling, et al.

Journal of Virology|February 3, 2007

Rotavirus infection alters peripheral T-cell homeostasis in children with acute diarrheaYuhuan Wang, Penelope H Dennehy, Harry L Keyserling, et al.

Vaccine|February 1, 2003

Revaccination of healthy nonresponders with hepatitis B vaccine and prediction of seroprotection responseMyong-Jin Kim, Anne N Nafziger, Clayton D Harro, et al.

Pediatrics|March 3, 2007

Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004Carrie M Shuler, Martha Iwamoto, Carolyn Buxton Bridges, et al.

Pediatrics|August 5, 2003

Vancomycin use in hospitalized pediatric patientsHarry L Keyserling, Ronda L Sinkowitz-Cochran, James M Harris, et al.

Vaccine|April 29, 2014

Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trialTracy Pondo, Charles E Rose, Stacey W Martin, et al.

Pediatrics|March 4, 2008

Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of ageTerry Nolan, David I Bernstein, Stan L Block, et al.

Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:

Pageof 2

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2005

Invasive infections with Haemophilus influenzae serotype a containing an IS1016-bexA partial deletion: possible association with virulenceBill G Kapogiannis, Sarah Satola, Harry L Keyserling, et al.

Expert Review of Vaccines|September 23, 2006

Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135Harry L Keyserling, Andrew J Pollard, Lisa M DeTora, et al.

Tropical Medicine & Surgery|September 16, 2014

Enrollment in YFV Vaccine Trial: An Evaluation of Recruitment Outcomes Associated with a Randomized Controlled Double-Blind Trial of a Live Attenuated Yellow Fever VaccinePaula M Frew, Eve T Shapiro, Lu Lu, et al.

BMC Infectious Diseases|March 19, 2010

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasonsLisa A Jackson, Manjusha J Gaglani, Harry L Keyserling, et al.

Journal of Virology|February 3, 2007

Rotavirus infection alters peripheral T-cell homeostasis in children with acute diarrheaYuhuan Wang, Penelope H Dennehy, Harry L Keyserling, et al.

Vaccine|February 1, 2003

Revaccination of healthy nonresponders with hepatitis B vaccine and prediction of seroprotection responseMyong-Jin Kim, Anne N Nafziger, Clayton D Harro, et al.

Pediatrics|March 3, 2007

Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004Carrie M Shuler, Martha Iwamoto, Carolyn Buxton Bridges, et al.

Pediatrics|August 5, 2003

Vancomycin use in hospitalized pediatric patientsHarry L Keyserling, Ronda L Sinkowitz-Cochran, James M Harris, et al.

Vaccine|April 29, 2014

Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trialTracy Pondo, Charles E Rose, Stacey W Martin, et al.

Pediatrics|March 4, 2008

Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of ageTerry Nolan, David I Bernstein, Stan L Block, et al.

Pageof 2